ADA-话题@MedSci

#ADA#

386篇内容 | 2806人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264663, encodeId=d7101264663b7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：ADAR1过度编辑多发性骨髓瘤的转录本，促进病程进展，是预后不良的标志之一, objectType=article, longId=145687, objectId=9f7914568ec9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f7914568ec9, replyNumber=0, likeNumber=100, createdTime=2018-08-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f7914568ec9, moduleTitle=Blood：ADAR1过度编辑多发性骨髓瘤的转录本，促进病程进展，是预后不良的标志之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f7914568ec9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264662, encodeId=77af126466293, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：Vadastuximab talirine联合低甲基化制剂用于CD33阳性的AML老年患者的疗效和安全性, objectType=article, longId=145294, objectId=fd6b145294fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd6b145294fe, replyNumber=0, likeNumber=67, createdTime=2018-07-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd6b145294fe, moduleTitle=Blood：Vadastuximab talirine联合低甲基化制剂用于CD33阳性的AML老年患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd6b145294fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264661, encodeId=fdf612646611f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=为什么把LADA称为“1.5型糖尿病”？, objectType=article, longId=145267, objectId=661b14526e36, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661b14526e36, replyNumber=0, likeNumber=49, createdTime=2018-07-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661b14526e36, moduleTitle=为什么把LADA称为“1.5型糖尿病”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=661b14526e36)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264660, encodeId=1e1d12646604e, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Diabetes：ADAMTS13缺陷会缩短实验性糖尿病小鼠的寿命, objectType=article, longId=142793, objectId=5d46142e93cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d46142e93cb, replyNumber=0, likeNumber=60, createdTime=2018-07-10, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d46142e93cb, moduleTitle=Diabetes：ADAMTS13缺陷会缩短实验性糖尿病小鼠的寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d46142e93cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264659, encodeId=b7081264659a7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=【2018年ICRNM现场精彩呈现】Adamasco Cupisti教授漫谈肾病营养治疗, objectType=article, longId=142629, objectId=36821426299f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36821426299f, replyNumber=0, likeNumber=51, createdTime=2018-07-08, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36821426299f, moduleTitle=【2018年ICRNM现场精彩呈现】Adamasco Cupisti教授漫谈肾病营养治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36821426299f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264658, encodeId=ee3112646588b, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=研究｜ADA/EASD糖尿病指南草案公布！糖尿病治疗中不得不提的新亮点有这些, objectType=article, longId=142606, objectId=930b14260662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930b14260662, replyNumber=0, likeNumber=52, createdTime=2018-07-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930b14260662, moduleTitle=研究｜ADA/EASD糖尿病指南草案公布！糖尿病治疗中不得不提的新亮点有这些, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=930b14260662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264657, encodeId=832c126465e69, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2018：度拉糖肽治疗的糖尿病患者真实世界研究数据公布！, objectType=article, longId=142475, objectId=64f71424e57d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64f71424e57d, replyNumber=0, likeNumber=80, createdTime=2018-07-06, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64f71424e57d, moduleTitle=ADA 2018：度拉糖肽治疗的糖尿病患者真实世界研究数据公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64f71424e57d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264656, encodeId=5515126465676, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, objectType=article, longId=142211, objectId=ce0814221166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce0814221166, replyNumber=0, likeNumber=0, createdTime=2018-07-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce0814221166, moduleTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce0814221166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264655, encodeId=e03412646554f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著, objectType=article, longId=140811, objectId=c58614081148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58614081148, replyNumber=0, likeNumber=86, createdTime=2018-06-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58614081148, moduleTitle=Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c58614081148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264654, encodeId=e35a126465411, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, objectType=article, longId=140780, objectId=68e0140e800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e0140e800a, replyNumber=0, likeNumber=81, createdTime=2018-06-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e0140e800a, moduleTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e0140e800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264653, encodeId=6f46126465382, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=夜间猝死发生率高，莫忽视“Brugada综合征”, objectType=article, longId=140673, objectId=b3411406e3fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3411406e3fb, replyNumber=0, likeNumber=67, createdTime=2018-06-14, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3411406e3fb, moduleTitle=夜间猝死发生率高，莫忽视“Brugada综合征”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3411406e3fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264652, encodeId=dbaa1264652f0, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：阻断iRhom2/ADAM17/TNFα信号通路可防止血友病性骨关节病的出血诱导性骨质丢失, objectType=article, longId=138735, objectId=1f72138e35f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f72138e35f1, replyNumber=0, likeNumber=81, createdTime=2018-05-23, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f72138e35f1, moduleTitle=Blood：阻断iRhom2/ADAM17/TNFα信号通路可防止血友病性骨关节病的出血诱导性骨质丢失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f72138e35f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264651, encodeId=5d0112646513d, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=中国循环杂志：阜外医院治疗Brugada 综合征经验：选择导管消融或能根治, objectType=article, longId=136338, objectId=ad8f13633800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8f13633800, replyNumber=0, likeNumber=68, createdTime=2018-04-26, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8f13633800, moduleTitle=中国循环杂志：阜外医院治疗Brugada 综合征经验：选择导管消融或能根治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad8f13633800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264650, encodeId=890412646501d, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=挑战心电图：梗死与Brugada综合症之鉴别, objectType=article, longId=135817, objectId=350e13581e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=350e13581e6d, replyNumber=0, likeNumber=61, createdTime=2018-04-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=350e13581e6d, moduleTitle=挑战心电图：梗死与Brugada综合症之鉴别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=350e13581e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264649, encodeId=9eae12646495c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JACC：Brugada综合征诱导的恶性室性心律失常, objectType=article, longId=135209, objectId=ba59135209c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba59135209c8, replyNumber=0, likeNumber=74, createdTime=2018-04-15, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba59135209c8, moduleTitle=JACC：Brugada综合征诱导的恶性室性心律失常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba59135209c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264648, encodeId=0bf3126464833, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira, objectType=article, longId=134758, objectId=7a56134e586f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a56134e586f, replyNumber=0, likeNumber=61, createdTime=2018-04-12, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a56134e586f, moduleTitle=艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a56134e586f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264647, encodeId=7c76126464e4d, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JACC：激发试验有助于诊断SADS高风险个体的Brugada综合征, objectType=article, longId=132378, objectId=3c321323e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c321323e828, replyNumber=0, likeNumber=57, createdTime=2018-03-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c321323e828, moduleTitle=JACC：激发试验有助于诊断SADS高风险个体的Brugada综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c321323e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264646, encodeId=45241264646c2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=病例分享：见到这种心电图，警惕Brugada综合征与猝死风险, objectType=article, longId=129784, objectId=64ba129e8484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ba129e8484, replyNumber=0, likeNumber=85, createdTime=2018-02-14, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ba129e8484, moduleTitle=病例分享：见到这种心电图，警惕Brugada综合征与猝死风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ba129e8484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264645, encodeId=dabd12646457a, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2018 年ADA糖尿病医学诊疗标准解读, objectType=article, longId=129690, objectId=172e12969033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172e12969033, replyNumber=0, likeNumber=19, createdTime=2018-02-13, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172e12969033, moduleTitle=2018 年ADA糖尿病医学诊疗标准解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172e12969033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264644, encodeId=d4af12646449f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=从全新CDS和ADA指南看糖尿病患者如何调脂治疗？, objectType=article, longId=128721, objectId=54bf128e21ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54bf128e21ee, replyNumber=0, likeNumber=81, createdTime=2018-02-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54bf128e21ee, moduleTitle=从全新CDS和ADA指南看糖尿病患者如何调脂治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54bf128e21ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：ADAR1过度编辑多发性骨髓瘤的转录本，促进病程进展，是预后不良的标志之一

2018-08-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：Vadastuximab talirine联合低甲基化制剂用于CD33阳性的AML老年患者的疗效和安全性

2018-07-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

为什么把LADA称为“1.5型糖尿病”？

2018-07-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Diabetes：ADAMTS13缺陷会缩短实验性糖尿病小鼠的寿命

2018-07-10

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

【2018年ICRNM现场精彩呈现】Adamasco Cupisti教授漫谈肾病营养治疗

2018-07-08

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

研究｜ADA/EASD糖尿病指南草案公布！糖尿病治疗中不得不提的新亮点有这些

2018-07-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2018：度拉糖肽治疗的糖尿病患者真实世界研究数据公布！

2018-07-06

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症

2018-07-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Lancet：Upadacitinib对传统合成缓解病情抗风湿药物效果不佳的类风湿性关节炎效果显著

2018-06-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状

2018-06-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

夜间猝死发生率高，莫忽视“Brugada综合征”

2018-06-14

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：阻断iRhom2/ADAM17/TNFα信号通路可防止血友病性骨关节病的出血诱导性骨质丢失

2018-05-23

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

中国循环杂志：阜外医院治疗Brugada 综合征经验：选择导管消融或能根治

2018-04-26

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

挑战心电图：梗死与Brugada综合症之鉴别

2018-04-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JACC：Brugada综合征诱导的恶性室性心律失常

2018-04-15

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

艾伯维关节炎新药upadacitinib抵达3期终点效果优于Humira

2018-04-12

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JACC：激发试验有助于诊断SADS高风险个体的Brugada综合征

2018-03-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

病例分享：见到这种心电图，警惕Brugada综合征与猝死风险

2018-02-14

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2018 年ADA糖尿病医学诊疗标准解读

2018-02-13

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

从全新CDS和ADA指南看糖尿病患者如何调脂治疗？

2018-02-04

科室
- - 订阅+
  - 更多科室
工具
服务